Overcoming limitations of current Antibody-Drug Conjugates (ADCs) by a novel linker technology

被引：1
|
作者：
Spycher, Philipp Rene [1 ]
Frei, Julia Carina [2 ]
Wehrmueller, Jori Elias [2 ]
Attinger-Toller, Isabella [1 ]
Grabulovski, Dragan [1 ]
Hechler, Torsten [3 ]
Kulke, Michael [3 ]
Pahl, Andreas [3 ]
Behe, Martin [2 ]
Schibli, Roger [2 ]
机构：
[1] ETH Honggerberg, Araris Biotech AG, Zurich, Switzerland
[2] Paul Scherrer Inst, Villigen, Switzerland
[3] Heidelberg Pharma Res GmbH, Ladenburg, Germany
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-LB-106
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-106
引用
收藏
页数：2
相关论文
共 50 条
  • [31] From Anthramycin to Pyrrolobenzodiazepine (PBD)-Containing Antibody-Drug Conjugates (ADCs)
    Mantaj, Julia
    Jackson, Paul J. M.
    Rahman, Khondaker M.
    Thurston, David E.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2017, 56 (02) : 462 - 488
  • [32] Antibody-drug conjugates (ADCs) for cancer therapy: Strategies, challenges, and successes
    Abdollahpour-Alitappeh, Meghdad
    Lotfinia, Majid
    Gharibi, Tohid
    Mardaneh, Jalal
    Farhadihosseinabadi, Behrouz
    Larki, Pegah
    Faghfourian, Babak
    Sepehr, Koushan Sineh
    Abbaszadeh-Goudarzi, Kazem
    Abbaszadeh-Goudarzi, Ghasem
    Johari, Behrooz
    Zali, Mohammad Reza
    Bagheri, Nader
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (05) : 5628 - 5642
  • [33] Antibody-Drug Conjugates (ADCs): A Novel Therapy for Triple-Negative Breast Cancer (TNBC)
    Gupta, Gaurav
    Hussain, Md Sadique
    Pant, Kumud
    Ali, Haider
    Thapa, Riya
    Bhat, Asif Ahmad
    CURRENT CANCER DRUG TARGETS, 2025, 25 (02) : 108 - 112
  • [34] Optimizing Lysosomal Activation of Antibody-Drug Conjugates (ADCs) by Incorporation of Novel Cleavable Dipeptide Linkers
    Salomon, Paulin L.
    Reid, Emily E.
    Archer, Katie E.
    Harris, Luke
    Maloney, Erin K.
    Wilhelm, Alan J.
    Miller, Michael L.
    Chari, Ravi V. J.
    Keating, Thomas A.
    Singh, Rajeeva
    MOLECULAR PHARMACEUTICS, 2019, 16 (12) : 4817 - 4825
  • [35] Design, synthesis and evaluation of novel, potent DNA alkylating agents and their antibody-drug conjugates (ADCs)
    Reid, Emily E.
    Archer, Katie E.
    Shizuka, Manami
    McShea, Molly A.
    Maloney, Erin K.
    Ab, Olga
    Lanieri, Leanne
    Wilhelm, Alan
    Ponte, Jose F.
    Yoder, Nicholas C.
    Chari, Ravi V. J.
    Miller, Michael L.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (17) : 2455 - 2458
  • [36] Optimizing lysosomal activation of antibody-drug conjugates (ADCs) by incorporation of novel cleavable dipeptide linkers
    Salomon, Paulin
    Harris, Luke
    Reid, Emily E.
    Maloney, Erin K.
    Wilhelm, Alan J.
    Miller, Michael L.
    Chari, Ravi V.
    Keating, Thomas A.
    Singh, Rajeeva
    CANCER RESEARCH, 2019, 79 (13)
  • [37] Current approaches for the purification of antibody-drug conjugates
    Matsuda, Yutaka
    JOURNAL OF SEPARATION SCIENCE, 2022, 45 (01) : 27 - 37
  • [38] Novel antibody-drug conjugates based on DXd-ADC technology
    Chen, Rong
    Ren, Zhiwen
    Bai, Lan
    Hu, Xuefang
    Chen, Yuchen
    Ye, Qiang
    Hu, Yuan
    Shi, Jianyou
    BIOORGANIC CHEMISTRY, 2024, 151
  • [39] Incidence and Mitigation of Corneal Pseudomicrocysts Induced by Antibody-Drug Conjugates (ADCs)
    Lindgren, Ethan S.
    Yan, Rongshan
    Cil, Onur
    Verkman, Alan S.
    Chan, Matilda F.
    Seitzman, Gerami D.
    Farooq, Asim V.
    Huppert, Laura A.
    Rugo, Hope S.
    Pohlmann, Paula R.
    Lu, Janice
    Esserman, Laura J.
    Pasricha, Neel D.
    CURRENT OPHTHALMOLOGY REPORTS, 2024, 12 (02) : 13 - 22
  • [40] Novel antibody-drug conjugates: current and future roles in gynecologic oncology
    Tymon-Rosario, Joan
    Zeybek, Burak
    Santin, Alessandro D.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2021, 33 (01) : 26 - 33
12345